GlobeNewswire Inc.··NaSyndax to Showcase Oncology Pipeline at Three Marquee Healthcare Conferences
Syndax Pharmaceuticals will present at major investor conferences in May-June 2026, featuring CEO Michael Metzger discussing the company's oncology strategy and pipeline developments.
SNDXinvestor conferencebiopharmaceutical